NetworkNewsBreaks – CytoDyn Inc. (CYDY) to Prese

NetworkNewsBreaks – CytoDyn Inc. (CYDY) to Present at Biotech Showcase Conference

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced that it will be presenting at the Biotech Showcase at the Hilton San Francisco Union Square in San Francisco, California on January 9, 2019 at 10:30 AM PT. An update on the company’s clinical development programs and objectives for leronlimab (PRO 140) will be co-presented by president and CEO Nader Pourhassan, Ph.D. and chief medical officer and vice chairman Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. The presentation will provide insights regarding the company’s plans for 2019, including details on its first BLA submission of PRO 140 anticipated to occur during the first half of 2019. Management will also discuss potential licensing opportunities for PRO 140 in China, France, Japan and the United States and will hold a Q&A segment following the presentation. A live webcast and replay of the presentation will be available on the investors section of the company’s website at http://ir.cytodyn.com for 90 days.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer